Pharmaceuticals, Biotechnology and Life Sciences
Bristol-Myers Squibb Company (NYSE:BMY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines…
The US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for the use of AstraZeneca’s…
Horizon Discovery Group has entered into an agreement with Roche Diagnostics to assist in the development of immunohistochemistry (IHC) assays.
According to the press release from Thursday, Teva said it needs to reduce total cost base by $3 billion by the end…
Probably depends on where you live, and how the older folks trust the new machinery, but there are questions raised…
Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive topline results from a pivotal Phase 2 clinical study of…
Hikma Pharmaceuticals PLC (rated Ba1 Moody’s / BB+ S&P, both stable) has announced that its wholly-owned US subsidiary West-Ward Pharmaceuticals…
The board of directors of Eli Lilly and Company (NYSE: LLY) today announced an 8 percent increase in its quarterly…
Kite, a Gilead Company, announced updated results from the ongoing Phase 1/2 ZUMA-3 study of KTE-C19, a CD19 chimeric antigen…
Alexion Pharmaceuticals’s data from two Phase 1b/2 studies of ALXN1210, the company’s investigational long-acting C5 complement inhibitor, in patients with…